Search

everythinglearnresearchcommunity

for

Search:↓

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.